Lantheus Holdings, Inc. develops and commercializes radiopharmaceuticals for diagnostic imaging and therapeutic applications. The company focuses on delivering products that assist in the detection and treatment of various diseases, including cancer and neurological disorders. Lantheus serves healthcare providers and patients primarily in the United States and internationally.
